Literature DB >> 32042729

Toll-like receptor 4 (TLR4) deficiency aggravates dextran sulfate sodium (DSS)-induced intestinal injury by down-regulating IL6, CCL2 and CSF3.

Yun-Jie Shi1, Shi-Jie Hu2, Quan-Quan Zhao1, Xiao-Shuang Liu1, Cong Liu3, Hao Wang1.   

Abstract

BACKGROUND: Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) that causes long-lasting inflammation and ulcers in the human digestive tract. The repair role of TLR4 in the intestinal epithelium is still unknown.
METHODS: By comparing to wild-type (WT) mice, Toll-like receptor 4 (TLR4)-knockout mice (TLR4-KO) were used as dextran sulfate sodium (DSS)-induced colitis models to explore the role of TLR4 signaling in intestinal injury. High-throughput RNA-Seq, RT-qPCR and ELISA were performed to screen and verify key differences in gut genes between WT and TLR4-KO mice. Functional study of core dysregulated factors was performed in intestinal cell lines.
RESULTS: We found that DSS-induced intestinal injury was aggravated by LPS (TLR4 agonist) and TLR4-KO. When compared to WT mice, IL6, CCL2, CSF3, IL11, Ccnb1, Ccnd1 and TNF-α significantly decreased and Fas and FasL have increased in the gut of TLR4-KO mice. IL6, CCL2, CSF3, Fas and FasL have all increased in CT-26 cells treated with LPS. Combined with the above data and KEGG enrichment, it can be assumed that TLR4-KO might aggravate DSS-induced intestinal damage by attenuating cell cycle, cytokine-cytokine receptor interaction, and Toll-like receptor signaling pathway, and enhancing the apoptosis pathway. In the functional study of core dysregulated factors, it was found that LPS, IL6, IL11, CSF3, CCL2, S100A8, S100A9 and Mmp3 have improved viability of colon cancer cell lines and decreased apoptosis rate of mouse colon cancer cells when these were treated with DSS. However, Jo-2 (Fas agonistic monoclonal antibody) played the opposite role in colon cancer cells treated with DSS.
CONCLUSIONS: TLR4 had a repairing effect on DSS-induced intestinal damage and it up-regulate IL6, CCL2 and CSF3. Fas and FasL enhanced DSS-induced colon injury in mice, but might have little to do with TLR4 signaling. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  CCL2; CSF3; IL6; Toll-like receptor 4 (TLR4); dextran sulfate sodium

Year:  2019        PMID: 32042729      PMCID: PMC6989995          DOI: 10.21037/atm.2019.12.28

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  30 in total

1.  Ectopic expression of SIGIRR in the colon ameliorates colitis in mice by downregulating TLR4/NF-κB overactivation.

Authors:  Jinlin Liu; Yanxia Chen; Dongsheng Liu; Wei Liu; Sijun Hu; Nanjin Zhou; Yong Xie
Journal:  Immunol Lett       Date:  2017-01-30       Impact factor: 3.685

Review 2.  The genetic background of inflammatory bowel disease: from correlation to causality.

Authors:  Werna Tc Uniken Venema; Michiel D Voskuil; Gerard Dijkstra; Rinse K Weersma; Eleonora Am Festen
Journal:  J Pathol       Date:  2016-11-15       Impact factor: 7.996

3.  Modeling qRT-PCR dynamics with application to cancer biomarker quantification.

Authors:  Inna Chervoneva; Boris Freydin; Terry Hyslop; Scott A Waldman
Journal:  Stat Methods Med Res       Date:  2017-05-14       Impact factor: 3.021

4.  Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors.

Authors:  E Cario; I M Rosenberg; S L Brandwein; P L Beck; H C Reinecker; D K Podolsky
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

5.  Critical role of toll-like receptor 4 (TLR4) in dextran sulfate sodium (DSS)-Induced intestinal injury and repair.

Authors:  Yun-Jie Shi; Hai-Feng Gong; Quan-Quan Zhao; Xiao-Shuang Liu; Cong Liu; Hao Wang
Journal:  Toxicol Lett       Date:  2019-08-20       Impact factor: 4.372

6.  Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation.

Authors:  Nikolaos Patsoukis; Julia Brown; Victoria Petkova; Fang Liu; Lequn Li; Vassiliki A Boussiotis
Journal:  Sci Signal       Date:  2012-06-26       Impact factor: 8.192

7.  Identification of potential therapeutic target genes and mechanisms in non-small-cell lung carcinoma in non-smoking women based on bioinformatics analysis.

Authors:  W Zhou; M Yin; H Cui; N Wang; L-L Zhao; L-Z Yuan; X-P Yang; X-M Ding; F-Z Men; X Ma; J-R Na
Journal:  Eur Rev Med Pharmacol Sci       Date:  2015-09       Impact factor: 3.507

Review 8.  Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage.

Authors:  Ansar Karimian; Yasin Ahmadi; Bahman Yousefi
Journal:  DNA Repair (Amst)       Date:  2016-04-22

9.  Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation.

Authors:  Cole Trapnell; Brian A Williams; Geo Pertea; Ali Mortazavi; Gordon Kwan; Marijke J van Baren; Steven L Salzberg; Barbara J Wold; Lior Pachter
Journal:  Nat Biotechnol       Date:  2010-05-02       Impact factor: 54.908

10.  Circular RNA hsa_circ_0068871 regulates FGFR3 expression and activates STAT3 by targeting miR-181a-5p to promote bladder cancer progression.

Authors:  Weipu Mao; Xin Huang; Longsheng Wang; Ziwei Zhang; Mengnan Liu; Yan Li; Ming Luo; Xudong Yao; Jie Fan; Jiang Geng
Journal:  J Exp Clin Cancer Res       Date:  2019-04-18
View more
  14 in total

1.  Epithelial-Specific TLR4 Knockout Challenges Current Evidence of TLR4 Homeostatic Control of Gut Permeability.

Authors:  Elise E Crame; Joanne M Bowen; Kate R Secombe; Janet K Coller; Maxime François; Wayne Leifert; Hannah R Wardill
Journal:  Inflamm Intest Dis       Date:  2021-09-28

2.  Periplaneta americana extract ameliorates dextran sulfate sodium-induced ulcerative colitis via immunoregulatory and PI3K/AKT/NF-κB signaling pathways.

Authors:  Lianli Ni; Qian Lu; Miao Tang; Lu Tao; Hairong Zhao; Chenggui Zhang; Yun Yu; Xiumei Wu; Heng Liu; Ri Cui
Journal:  Inflammopharmacology       Date:  2022-03-18       Impact factor: 4.473

3.  TLR4 activation inhibits the proliferation and osteogenic differentiation of skeletal muscle stem cells by downregulating LGI1.

Authors:  Haiying Tao; Xiaoyan Tang; Hai Tao
Journal:  J Physiol Biochem       Date:  2022-03-16       Impact factor: 5.080

4.  Transcriptome Analysis Reveals Possible Immunomodulatory Activity Mechanism of Chlorella sp. Exopolysaccharides on RAW264.7 Macrophages.

Authors:  Siwei Wu; Hongquan Liu; Siyu Li; Han Sun; Xiumiao He; Ying Huang; Han Long
Journal:  Mar Drugs       Date:  2021-04-14       Impact factor: 5.118

5.  Identification of Pharmacological Autophagy Regulators of Active Ulcerative Colitis.

Authors:  Peishan Qiu; Lan Liu; Jun Fang; Meng Zhang; Haizhou Wang; Yanan Peng; Min Chen; Jing Liu; Fan Wang; Qiu Zhao
Journal:  Front Pharmacol       Date:  2021-12-01       Impact factor: 5.810

6.  Integrated whole transcriptome and small RNA analysis revealed multiple regulatory networks in colorectal cancer.

Authors:  Hibah Shaath; Salman M Toor; Mohamed Abu Nada; Eyad Elkord; Nehad M Alajez
Journal:  Sci Rep       Date:  2021-07-14       Impact factor: 4.379

7.  Differential mRNA and miRNA Profiles Reveal the Potential Roles of Genes and miRNAs Involved in LPS Infection in Chicken Macrophages.

Authors:  Qi Zhang; Jie Wang; Jin Zhang; Jie Wen; Guiping Zhao; Qinghe Li
Journal:  Genes (Basel)       Date:  2021-05-17       Impact factor: 4.096

Review 8.  Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease.

Authors:  Linshan Duan; Shuyu Cheng; Long Li; Yanling Liu; Dan Wang; Guoyan Liu
Journal:  Front Pharmacol       Date:  2021-07-14       Impact factor: 5.810

9.  Bioinformatic Analysis Identified Hub Genes Associated with Heterocyclic Amines Induced Cytotoxicity of Peripheral Blood Mononuclear Cells.

Authors:  Xinyang Li; Lu Dong; Huaning Yu; Yan Zhang; Shuo Wang
Journal:  Genes (Basel)       Date:  2021-11-25       Impact factor: 4.096

Review 10.  TLR4 signaling in the development of colitis-associated cancer and its possible interplay with microRNA-155.

Authors:  Jie Guo; Mengfan Liao; Jun Wang
Journal:  Cell Commun Signal       Date:  2021-09-03       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.